We have generated a bioinspired tunable system of hyaluronic acid (HyA)-based hydrogels for MatrixAssisted Cell Transplantation (MACT). With this material, we have independently evaluated matrix parameters such as adhesion peptide density, mechanical properties, and growth factor sequestering capacity, to engineer an environment that imbues donor cells with a milieu that promotes survival and engraftment with host tissues after transplantation. Using a versatile population of Sca-1 þ /CD45 À cardiac progenitor cells (CPCs), we demonstrated that the addition of heparin in the HyA hydrogels was necessary to coordinate the presentation of TGFb1 and to support the trophic functions of the CPCs via endothelial cell differentiation and vascular like tubular network formation. Presentation of exogenous TGFb1 by binding with heparin improved differentiated CPC function by sequestering additional endogenously-produced angiogenic factors. Finally, we demonstrated that TGFb1 and heparin-containing HyA hydrogels can promote CPC survival when implanted subcutaneously into murine hind-limbs and encouraged their participation in the ensuing neovascular response, which included blood vessels that had anastomosed with the host's blood vessels.
Introduction
Over the past decade, stem cell transplantation therapy has started to fulfill its long held promise as a means of promoting functional regeneration of tissues that have been damaged by injury and disease. As new cell therapies have translated into clinical studies, modest results have been reported for regeneration in several tissue types, including cardiac [1, 2] , skeletal muscle [3] , and liver [4] . These studies pointed out several technological challenges regarding relevant cell transplantation parameters that must be optimized before these treatment options become widely available. One pressing problem is that immediately after transplantation into damaged tissue, donor cells encounter a harsh environment with substantial death-promoting stimuli (e.g., hypoxia, reactive oxygen species, etc.), and the vast majority (>90%) of donor cells are lost to necrosis and/or apoptosis within hours to days after transplantation [5, 6] . Based on the poor cell survival rate after transplantation, there has been limited evidence that the donor cells can engraft and functionally integrate with the damaged tissue to participate directly to regeneration processes [7e9] . Instead, recent evidence indicates that paracrine signaling of the transplanted cells is the major contributor to any significant tissue regeneration observed [10e12] .
One strategy for improving the survival of transplanted stem or progenitor cells, termed Matrix-Assisted Cell Transplantation (MACT), is to engineer a materials-based environment that promotes pro-survival paracrine signaling immediately after transplantation, and subsequently stimulates mechanisms of cell engraftment with the host tissues [13e19] . Matrigel™ was initially proposed as a material for MACT, but heterogeneous batch-to-batch material composition, quality control and biological sourcing issues, and the inability to engineer compositional changes have substantially impeded its clinical translation. Therefore, recent advances in this field have focused on transplanting cells with other natural or synthetic matrices [20e25] . Most work has focused on naturally occurring biopolymers such as collagen, alginate, fibrin, chitosan, and hyaluronic acid (HyA), with alginate and fibrin modestly attenuating the negative remodeling process. Ideally a material for MACT would exploit not only the pro-survival potential of naturally occurring biopolymers, but also allow for a wide design space to modulate parameters that are relevant in a pro-healing native extracellular matrix, including the ability to harness endogenously synthesized growth factors by sequestering them in the matrix.
To overcome the limitations that are currently associated with MACT, we have developed hyaluronic acid (HyA) -based hydrogels that were generated using a tunable method of synthesis. HyA was selected as the primary component of this structural matrix since it is biocompatible, biodegradable, non-immunogenic, and plays a critical role in fostering tissue development and repair [26] . Our method of synthesis enabled independent control over the hydrogel mechanical properties and biological features, including: (1) the density of peptide sequences for cell attachment via binding to integrin receptors; (2) matrix modulus; (3) the cell-mediated degradation kinetics by selective the MMPs [21] ; and, (4) sequestration of exogenously added or endogenously synthesized growth factors via heparin conjugated within the hydrogel. Previously reported materials for MACT have not simultaneously explored the effect of all these matrix parameters on transplanted cell survival and engraftment.
Regarding the use of heparin, it is well known that soluble growth factors have their effect on cells for limited time due to their poor stability, soluble presentation, and short half-life in vivo. A number of groups have demonstrated that heparin can sequester and release exogenously added growth factors that ultimately improve wound healing and tissue regeneration [27e32]. Therefore, thiolated heparin macromers were incorporated into HyA based hydrogels for solid-phase presentation and prolonged retention of growth factors that were either added exogenously or endogenously produced by the entrained cells.
Using this easily tunable hydrogel system, the objective our study was to demonstrate how a suitable material for MACT can support donor cell survival during transplantation and encourage donor cell integration with the host tissue. In this study, we focused on murine cardiac progenitor cells (CPCs), a pluripotent population of GFP þ Sca-1 þ /CD45 À cells that contribute to cardiac regeneration, at least in part by undergoing neovascular differentiation that is characteristic of endothelial cells [10, 33] . With this versatile cell type, we examined how the biochemical and mechanical parameters of the HyA hydrogels influenced: (1) CPC survival, proliferation, and differentiation in vitro; and, (2) CPC survival and functional integration via neovascularization in vivo.
Materials & methods

Materials
Hyaluronic acid (HyA, sodium salt, 1.0 MDa and 500 kDa) was generously donated by Lifecore Biomedical (Chaska, MN). Adipic dihydrazide (ADH), 1-ethyl-3-[3-(dimethylamino)propyl] carbodiimide (EDC), sodium hydroxide (NaOH), hydrochloric acid (HCl) and 1-hydroxybenzotriazole (HOBt) were purchased from Aldrich (Milwaukee, WI). Dimethyl sulfoxide (DMSO), N-Acryloxysuccinimide (NAS), acetone, ethanol were obtained from Fisher Scientific (Waltham, MA). Paraformaldehyde (16% in H 2 O) was obtained from Electron Microscopy Sciences (Hartfield, PA). Calcein was purchased from BD Biosciences (Pasadena, CA). The MMP-degradable crosslinker peptide (CQPQGLAKC) and the 15 amino-acid adhesion peptide (CGGNGEPRGDTYRAY), bsp-RGD(15), were synthesized by American Peptide (Sunnyvale, CA). Dialysis membranes (10,000 MWCO, SpectraPor Biotech CE) were purchased from Spectrum Laboratories (Rancho Dominguez, CA). All chemicals were used as received. All cell culture reagents were purchased from Invitrogen (Carlsbad, CA). 1Â Dulbecco's phosphate buffered saline (DPBS) was purchased from Invitrogen.
Synthesis of AcHyA hydrogel components
Functionalization of HyA with acrylate groups using a two-step synthesis method and functionalization of heparin with a thiol group were performed as follows ( Supplementary Fig. S1 ):
Acrylation of HyA
A HyA derivative carrying hydrazide groups (HyA-ADH) was synthesized using a previously reported method [34] . Specifically, 30 molar excess of ADH was added to HyA in deionized (DI) water (100 mL, 3 mg/ml). Solution pH was adjusted to 6.8 using 0.1 M NaOH and 0.1 M HCl. EDC (3 mmol) and HOBt (3 mmol) were dissolved separately in DMSO/water (1/1 volume ratio, 3 mL) and added to the HyA solution sequentially. The solution was allowed to react for 24 h, and the pH was maintained at 6.8 for at least the first 6 h. After 24 h, the solution pH was adjusted to 7.0 and exhaustively dialyzed against DI water. Then, NaCl was added to produce a 5% (w/v) solution, and HyA-ADH was precipitated in 100% ethanol. The precipitate was redissolved in H 2 O and dialyzed again to remove the salt. Subsequently, NAS (700 mg) was reacted to the HyA-ADH solution (300 mg, 100 mL DI water) to generate acrylate groups on the HyA [22] . The product was then lyophilized for 3 days to obtain acrylated HyA (AcHyA). Using a previously described analysis [35] , proton ( 1 H) NMR confirmed that~28% of the available carboxyl groups were conjugated with acrylate groups on the final acrylated HyA product (AcHyA; Supplementary Fig. S2 ).
Synthesis of thiolated heparin (heparin-SH)
Heparin-SH synthesis was adapted from a previous report [36] . Heparin (50 mg) was dissolved in DI water at a concentration of 5 mg/mL and reacted with an excess amount of cystamine in the presence of EDC and HOBt at pH 6.8 for 5 h at room temperature. Next, the reaction solution was exhaustively dialyzed using a dialysis cassette to remove all small molecules not attached to heparin, and then the reaction product was lyophilized. After that, a 10-fold molar (moles per COOH of heparin) excess of tris (2-carboxyethyl) phosphine (TCEP) was added to reduce the oxidized disulfide groups in order to reduce any disulfide bonds that had formed between thiol groups. This solution was allowed to react for 3 h at pH 7.5 and then adjusted to pH 5.0 by the addition of 1.0 N HCl. The acidified solution was dialyzed against dilute HCl (pH 5.0) containing 100 mM NaCl, followed by dialysis against dilute HCl at pH 5.0. Then heparin-SH was lyophilized for 3 days, and the percentage of conjugation of thiol groups on the final product (heparin-SH) was determined by colorimetric Ellman assay.
Synthesis of HyA hydrogels
Prior to making HyA hydrogels, AcHyA-RGD derivative was synthesized by reacting CGGNGEPRGDTYRAY (bsp-RGD(15)) (10 mg) with AcHyA solution (25 mg, 10 mL DI water) at room temperature. AcHyA (13.3 mg/mL), AcHyA-RGD (20 mg/ mL), and heparin-SH (0.013 mg/mL) were dissolved in 0.3 mL of triethanolaminebuffer (TEOA; 0.3 M, pH 8), and incubated for 15 min at 37 C. HyA hydrogels were generated by in situ crosslinking of the HyA precursors with the MMP-13-cleavable peptide sequence CQPQGLAKC (50 mL TEOA buffer) [21, 37] . Viscoelastic properties of the hydrogel were determined by an oscillatory rheometer (MCR 302 Modular Compact Rheometer; Anton Paar, Ashland, VA) with a parallel plate geometry (25 mm diameter) under 10% constant strain and frequency ranging from 0.1 Hz to 10 Hz.
Incorporation of TGF-b1 and measurement of retention kinetics
Hydrogel macromers of AcHyA (13.3 mg/mL), AcHyA-RGD (20 mg/mL), and heparin-SH (0.013 mg/mL) were dissolved at various ratios (Supplementary Table S1) in 0.3 mL of triethanolamine-buffer (TEOA; 0.3 M, pH 8) and incubated for 15 min at 37 C. Then, TGFb1 (350 ng, Cell Signaling Technology, Danvers, MA) was mixed in the solution of HyA derivatives and incubated for another 15 min at 37 C. To determine the release kinetics, TGFb1 containing HyA hydrogels were transferred to cell culture inserts (Millipore Corporation, Billerica, MN) and TGFb1 was allowed to release into 400 mL of cell culture media per well. At predetermined time points over the course of 3 weeks, the supernatant was withdrawn and fresh media was replenished, and the mass of TGFb1 in each supernatant was determined with sandwich ELISA kits (RayBiotech, Inc, Norcross GA) ( Supplementary Fig. S5a,b) . Retention of TGFb1 was calculated by the subtraction of released TGFb1 from the calculated initial loading amount of TGFb1 ( Supplementary Fig. S5a) . Similarly, retention kinetic of bovine serum albumin (BSA) from HyA hydrogels (3 wt.% with 100% crosslinked without heparin) was measured ( Supplementary Fig. S5b ).
Cell culture, cell viability, adhesion and proliferation
À CPCs were isolated and cultured in Iscove's Modified Dulbecco's Medium(IMDM) basal media containing 10% Fetal bovine serum (FBS) and 1% PenicillineStreptomycin (PS) as previously described [10] . For cell encapsulation in the HyA hydrogels, confluent cells were trypsinized, collected cells were encapsulated at a density of 5 Â 10 6 cells/mL in HyA hydrogel. Before adding the cell culture media, cell-gel constructs were incubated for 30 min at 37 C to allow sufficient crosslinking to occur for gelation. Cell viability in the hydrogel was assessed by a Live/Dead staining kit (Invitrogen), and cell attachment was characterized by F-actin staining. Cell proliferation inside the hydrogels was quantified using the Alamar blue assay [38, 39] . Tubule quantification was performed on zstacked confocal images of CD31 staining using FIJI (National Institutes of Health, Bethesda, MD). Before processing the images FIJI, single color image z-stacks were stitched together and converted to an 8-bit RGB stack, and noise outliers were removed. Results are reported as the average of three imaging locations in each sample.
Immunocytochemistry
For immunocytochemistry, hydrogel samples were fixed using 4% (v/v) paraformaldehyde for 30 min and permeabilized with 0.1% Triton X-100 for 5 min. After blocking with 3% BSA for 1 h, hydrogel samples were incubated overnight at 4 C with a 1:200 dilution of primary antibody (rabbit anti-CD31 IgG). After washing the cells 3Â with PBS, hydrogel samples were incubated with a 1:200 dilution of goat anti-rabbit AlexaFluor Texas red IgG (Invitrogen, Molecular Probes) for 2 h at RT. Prior to imaging, cell nuclei were stained with DAPI for 5 min at RT. Cell-gel constructs were visualized using a Prairie two photon/confocal microscope (Prairie Technologies, Middleton, WI).
Response surface methodology
Data collected from the CPC proliferation and tubule quantification was transformed into a response surface by fitting the nine data points to a quadratic response surface with respect to two factors: stiffness of matrix and RGD concentration. JMP statistical software (SAS, North Carolina, USA) was used to fit the quadratic equation using least squares regression.
Flow cytometry
Cells entrained within the hydrogels were fixed with 4% paraformaldehyde for 30 min and permeabilized with 0.1% Triton for 5 min. After blocking with Fc-isotope controls for 10 min, the cells were stained with Allophycocyanin (APC)-conjugated anti-CD31 (PECAM-1) antibody or APC-conjugated anti-CD144 (VE-cadherin) antibody at 1:100 dilution for 1 h in dark. The hydrogels were then degraded by incubating them with 100 unit/mL hyaluronidase for 4 h to release the encapsulated cells. The stained cells were then pelleted by centrifugation, rinsed twice in PBS, passed through a 36-mm mesh cell strainer, and analyzed using a FC500 FACS Vantage cell sorter (BD Biosciences; see Supplementary Fig. S6a ,b).
Mouse angiogenesis protein profiler array
To measure the effect of the hydrogel on the expression of angiogenesis factors, we prepared hydrogels with entrained CPCs as described previously. After 12 days the supernatant was removed and retained for analysis. To measure the concentration of angiogenic factors that were expressed by the CPCs and retained within the matrix, the hydrogels were first washed with PBS and then degraded by the addition of hyaluronidase (100 unit/mL) at 37 C for 6 h. Subsequently, the degraded hydrogels were incubated with heparinase I, II & III (2.5 unit/mL each) at 37 C for another 6 h to eliminate heparin binding with the sequestered proteins. Next, the degraded hydrogels were centrifuged and the supernatant was collected for measurement of sequestered proteins in the hydrogels. The synthesized endogenous angiogenesis-associated proteins by the CPCs were measured using a mouse angiogenesis protein profiler array (R&D Systems, Minneapolis, MN) following the manufacturer's instructions.
In these experiments, an additional control was included consisting of HyA-P with soluble TGFb1 at an equivalent concentration as the HyA-PHT hydrogels. The array was visualized by a chemiluminescence substrate using Bio-Rad ChemiDoc XRS System. The relative expression of the angiogenesis proteins produced by the CPCs in each of the hydrogels was measured by comparing the pixel density of each chemiluminescence image (Fig 5 a, b ).
Transduction of firefly luciferase (fLuc) into CPCs
Lentiviral vectors were packaged as previously described [40] . Briefly, third generation vectors were packaged by transient transfection of 293T cells cultured in IMDM media, supplemented with 10% FBS and 1% PennStrep, using a calcium phosphate precipitation protocol with 10 mg of a lentiviral transfer vector encoding firefly luciferase under the human ubiquitin promoter (hUb-fLuc), 5 mg of pMDLg/ pRRE, 1.5 mg of pRSV Rev, and 3.5 mg of pcDNA IVS VSV-G. Culture medium was changed 12 h post-transfection, and viral supernatant was recovered 48 h and 72 h post-transfection and filtered using a 0.45 mm filter. Viral particles were concentrated via ultracentrifugation and resuspended in PBS.
CPC's were stably transduced with concentrated viral particles at a multiplicity of infection (MOI) of~3 and culture medium was changed 24 h post-transduction. Luciferase activity was assayed in vitro with the Firefly Luciferase Assay System (Promega) by using a single-sample illuminometer (70% sensitivity, 2 s measurement delay, 10 s measurement read).
In vivo implantation study
To evaluate the ability of HyA based hydrogels to promote CPC survival and their ability to direct cell fate in vivo, a CPC/hydrogel suspension (100 mL) containing firefly luciferase (fLuc) transducted CPCs (5 millions cells/mL) was injected into the subcutaneous region of the anterior tibialis of syngeneic C57BL/6 mice. As a control, an equivalent concentration and volume of CPCs suspended in PBS was injected into the subcutaneous region of the anterior tibialis of syngeneic C57BL/6 mice. In vivo cell proliferation and survival was assessed at predetermined time points on the basis of the measured radiance (p/s/cm 2 /SR) of the bioluminescent implants. To evaluate the vascular relationship of host and implant, cardiac perfusion of AF568-conjugated isolectin GS-IB4 from Griffonia simplicifolia (Invitrogen) was performed on the implanted mice. To examine the implants for matrix production and neovascular response, explants were harvested and fixed in 4% paraformaldehyde, cryosectioned, and examined with two-photon confocal microscope (Prairie Technologies, Middleton, WI).
Statistical analysis
All quantitative measurements were performed on at least triplicate sIPNs. All values are expressed as means ± standard deviations (SD). One-way ANOVA with post-hoc Tukey tests were used to compare treatment groups in the quantitative measurements and p < 0.05 was used to assess statistical significance.
Results
3.1.
Defined material parameters were achieved using acrylated HyA (AcHyA) hydrogel synthesis For this study, two discrete macromers were synthesized: AcHyA conjugated with the cell adhesion peptide bsp-RGD(15) (AcHyA-RGD) [41] and AcHyA conjugated with the glycosaminoglycan heparin (AcHyA-Heparin) ( Supplementary Fig. S1 and S2 for detailed synthesis and characterization of AcHyA components). The adhesion peptide was chosen based on a screen of seven peptides that are known to promote integrin engagement, cell adhesion and proliferation of cardiac progenitor cells (Supplementary Fig. S3 ). HyA hydrogels with a range of biochemical and physical parameters (Supplementary Table S1 ) were made by in situ crosslinking of AcHyA components (AcHyA-RGD, AcHyA-Heparin) via the Michaeltype addition reaction with short matrix metalloproteinase (MMP-13) degradable peptide sequences presenting terminal cysteine residues (Fig. 1a, b) . Gelation of the 3 wt.% hydrogel with 100% crosslinking density (defined as moles of thiol on the peptide crosslinker to moles of acrylate groups on the AcHyA) was initiated after approximately 60 s and was completed within 15 min, as determined by a time-sweep at 0.1% strain and 1 Hz using an oscillatory rheometer (Fig. 1c) . The viscoelastic properties, gelation kinetics, mass swelling ratios (Q m ), and sol fractions of the resulting hydrogels were dependent on both the weight percentage of AcHyA and the MMP crosslinking density (Supplementary Fig. S4 ). Importantly, low sol fraction of HyA hydrogels indicated a higher relative efficiency of HyA crosslinking in the network, and that they were highly hydrolytically stable.
Retention kinetics of growth factors within the aforementioned HyA hydrogels was controlled by the relative ratio of exogenously added growth factor and heparin in the hydrogel ( Supplementary  Fig. S5 ) [28e30] . Added TGFb1 in the hydrogel associated with the added heparin via a non-covalent, charge-dependent interaction. Initial loading, release rate and retention at day 21 was dependent on heparin content and TGFb1 concentration in the hydrogels (Supplementary Table S2 ). For example, covalent conjugation of 0.03 wt.% heparin in the HyA network retained 70% of TGFb1 within the hydrogel for 21 days (Fig. 1d) . HyA hydrogels without heparin retained less than 30% of the exogenously added TGFb1 after 12 days, whereas a highly negatively charged protein BSA was completely released from the HyA hydrogel (3 wt.% with 100% crosslinking without heparin) within 72 h. The mechanism for growth factor retention was, therefore, a combination of TGFb1 binding directly with heparin via the protein's heparin-binding domain, and charge association between the oppositely charged growth factor and HyA [28, 29] (Fig. 1d and Supplementary Fig. S5b ).
CPC adhesion and proliferation was dependent on the AcHyA hydrogel parameters
To evaluate the effect of each AcHyA component on CPC survival, adhesion, and proliferation, four formulations of HyA hydrogels were synthesized: (1) AcHyA only (HyA); (2) AcHyA and AcHyA-RGD (HyA-P); (3) AcHyA, AcHyA-RGD and AcHyA-Heparin (HyA-PH); and, (4) AcHyA, AcHyA-RGD and AcHyA-Heparin-TGFb1 (HyA-PHT). All four hydrogel combinations contained 3 wt.% AcHyA with 100% crosslinking, which yielded a shear storage modulus of 850 Pa. For these experiments, the bsp-RGD(15) peptide, heparin, and TGFb1 concentrations were 380 mM, 11.4 mg/ml, and 40 nM TGFb1, respectively, and were chosen based on previous reports [28,37,42e44] . Minimal (<5%) CPC death was observed in each of the hydrogels, independent of the combination of components used (Fig. 2) . CPCs seeded within all three hydrogels containing AcHyA-RGD exhibited robust spreading and elongated cellular morphology, whereas CPCs seeded in the hydrogel containing only HyA remained rounded and did not assume typical adherent cell morphology (Fig. 2a) . We calculated the area of CPC spreading in the hydrogels and found the cells in HyA-PHT spread the most (1600 mm 2 ). However, the relative difference in cell area for any of the hydrogels containing AcHyA-RGD was small compared to the area of rounded cells in the HyA hydrogel (660 mm 2 , Fig. 2b ). The proliferation of CPCs in the same four hydrogels was quantified over 21 days (Fig. 2c) . Statistically, there was no significant difference between any of the gels at Days 3 and 7, and only marginal proliferation was observed in the HyA hydrogel through day 21. By contrast, CPCs proliferated consistently from day 3 to day 21 in all three hydrogels containing AcHyA-RGD (i.e., HyA, HyA-PH and HyA-PHT). At day 14, HyA was significantly less than HyA-PH and HyA-PHT, and at day 21, both HyA and HyA-P were significantly less than the heparin-containing HyA-PH and HyA-PHT hydrogels (p < 0.05).
These results reveal that the adhesion peptide bsp-RGD(15) was required for CPC function in the AcHyA hydrogels, and the additional with heparin further enhanced the proliferation of CPCs. The HyA-PHT hydrogel was used to evaluate the effect of bsp-RGD(15) density and hydrogel stiffness on CPC proliferation using response surface methodology (RSM) to analyze the multiparametric data (Fig. 3) . CPC proliferation was linearly dependent on bsp-RGD (15) density within the range evaluated, whereas the effect of hydrogel stiffness was maximum at approximately 800 Pa. Furthermore, the matrix stiffness had greater influence on the (15) peptide and heparin as a growth factor presenting agent were synthesized by using bis-cysteine matrix metalloproteinase (MMP)-degradable peptide crosslinkers that reacted via the Michael-type addition to acryl groups on the functionalized HyA precursors. b, Images of polymerized hydrogel e red dye is for fiduciary purposes. c, The time required to initiate gelation, defined when the storage modulus (G 0 ) exceeds the loss modulus (G 00 ) occurred within 60 s. Gelation was considered complete when G 0 reached a plateau, and occurred within 15 min, depending on the weight ratio of HyA included in each hydrogel. d, Depending on the weight percentage of heparin present, HyA hydrogels (0.03 wt.% heparin) retain over 70% of the TGFb1 for up to 20 days. Hydrogel with a lower wt% of heparin (e.g., 0.01 wt.%) exhibited a slow and nearly zero order release kinetics. Gels without heparin released most of the TGFb1 by 10 days. There was minimum retention of BSA within the HyA hydrogels, which has acidic isoelectric point, confirming that molecular diffusion was not hindered by the crosslinking density of hydrogel. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) proliferation rate of the CPCs compared to peptide density, as the former appeared to dominate the response surfaces at every time point.
CPC formation into endothelial networks was controlled via AcHyA hydrogel parameters
The Sca-1 þ /CD45 À population of CPCs readily differentiate into endothelial cells under the appropriate induction conditions [10] . In this study, differentiation of Sca-1 þ /CD45 À population of CPCs into endothelial cells within the hydrogels was measured by immunostaining for CD31 and uptake of acetylated low-density lipoprotein (Ac-LDL) (Fig. 4a) , and quantified by flow cytometry for the EC-specific markers CD31 and VE-Cadherin. We studied the four formulations of HyA hydrogels used in the adhesion and proliferation studies and found all of the HyA gels containing bsp-RGD (15) significantly increased the expression of both EC markers (p < 0.05: Supplementary Fig. S6a ). Inclusion of TGFb1 increased the number of cells expressing CD31 relative to the HyA-P hydrogels, and also increased the number of cells expressing VE-cadherin relative to both the HyA-P and HyA-PH hydrogels. For CPCs in the HyA-PHT hydrogels, the expression of CD31 and VE cadherin increased significantly from days 3e12 (p < 0.05, Supplementary  Fig. S6b) , and a tubular network formed on day 6, which increased in density and complexity through day 12 ( Supplementary Fig. S6c) . Interestingly, the cellular network formation was only observed in HyA-PHT hydrogels (Fig. 4a) , which indicated exogenous TGFb1 presented in the network induced the tubule network formation, consistent with previous investigations demonstrating the role of TGFb1 to promote capillary tube formation by CPCs [44] and endothelial cells [45] in two-dimensional experiments.
To decouple the effect of heparin and TGFb1, we included control HyA-P hydrogels containing an equivalent concentration of soluble TGFb1 as the HyA-PHT hydrogel either in the media or polymerized within the gel. Tubular network formation was not evident in either HyA-P 'soluble' containing TGFb1 gels compared to HyA-PHT hydrogel (Fig. 4a, & Supplementary Figs. S10, S11) . Therefore, the presentation of TGFb1 by heparin substantially enhanced the network formation process, as an equimolar Fig. 2 . CPC Viability, proliferation, and adhesion in HyA hydrogels. (a, upper panels) The viability of CPCs encapsulated by the HyA-, HyA-P, HyA-PH and HyA-PHT hydrogels was high after one day of culture, as assessed by double staining with calcein (green, live cells) and propidium iodide (red, dead cells). (a, lower panels) CPCs were capable of adhering and spreading within the hydrogel networks containing the adhesive ligand bsp-RGD(15), as assessed by imaging for f-actin stress fibers (TRITC-phalloidin; red) and nuclei (DAPI; blue). b, The area of spread cells was enhanced significantly by the addition of adhesion peptide and TGFb1. c, Cell proliferation within the HyA hydrogels was affected by the presence of heparin and TGFb1, and at day 21, proliferation in both HyA and HyA-P were significantly less than HyA-PH and HyA-PHT hydrogels (ANOVA with Tukey, p < 0.05). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) concentration of TGFb1 supplied as a soluble mediator in HyAhydrogels lacking heparin was insufficient to generate a similar response.
Among the four hydrogels tested, the HyA-PHT was the only one that supported substantial cell proliferation, endothelial cell differentiation, and tubular network formation in the hydrogel, therefore, the HyA-PHT hydrogel was chosen to further study the effect of matrix modulus and peptide density on tube network formation, see Supplementary Table S1 for the concentration ranges used for each of these components. After culture for 12 days in HyA-PHT hydrogels, formation of tubular networks was dependent on both hydrogel modulus and peptide density (Fig. 4b) . Response of total tubule length to the bsp-RGD (15) peptide density was approximately linear within the range evaluated in this study. Similarly, the thickness of the tubules formed in HyA-PHT hydrogels exhibited a linear response to both hydrogel modulus and bsp-RGD (15) peptide density, although this tubule characteristic was more sensitive to the matrix stiffness parameter (Fig. 4c and d) . These complex threedimensional networks (Fig. 4e) , which appeared to contain a central lumen (Fig. 4f) , suggested that CPCs in the HyA-PHT hydrogels were capable of forming nascent vessels in vitro.
The AcHyA hydrogels encouraged CPCs to produce angiogenic cytokines
The effect of hydrogel components on CPC paracrine function was also investigated. CPCs were cultured for 12 days in the four HyA hydrogel combinations previously described (i.e., HyA, HyA-P, HyA-PH and HyA-PHT) and the concentration of secreted angiogenic factors retained by the hydrogel matrix were measured (Fig. 5) . Only low paracrine factor expression was observed by CPCs entrained in any of the hydrogels without TGFb1, and by contrast, the cells seeded in the HyA-PHT expressed high levels of angiogenic factors, including those stimulating vascular stabilization (Fig. 5a ), which were retained within the matrix at 12 days. By contrast, the cells seeded in HyA-P and treated with soluble TGFb1 stimulated a limited subset of paracrine factors (Fig. 5b) , where the expression levels in both the hydrogel and supernatant were lower relative to the HyA-PHT hydrogels.
The AcHyA hydrogels enhance CPC survival and neovascularization in vivo
The in vivo performance of the hydrogels in promoting CPC survival, differentiation, and engraftment was evaluated using a subcutaneous implantation model in syngeneic C57BL/6 mice. The CPCs were transduced with a constitutive firefly luciferase (fLuc) reporter to evaluate cell survival for over 30 days after implantation (Fig. 6a) . CPCs entrained in the HyA, HyA-PH, HyA-PHT hydrogels experienced a drop in bioluminescence (BLI) signal after 4 days, followed by a steady increase in BLI signal from day 4 to day 32 (Fig. 6b) . The early drop in BLI signal was anticipated due to the likely activity that occurs on the ubiquitin promoter as the CPCs recover from initial proteotoxic stresses encountered following in vivo implantation Fig. 3 . Dependency of cell proliferation on hydrogel stiffness and adhesion peptide density. a, RSM plots of CPC proliferation in HyA-PHT hydrogels with various moduli and concentrations (120e380 mM) of the cell adhesive ligand bsp-RGD (15) . CPC proliferation was dose-dependent on the RGD density, and maximum at~800 Pa. All data was normalized to the cell number (3.48 Â 10 5 ) in hydrogels at day 3 data. b, Kinetic observations of CPC proliferation as a function of hydrogel stiffness in HyA-PHT hydrogels shown at three different bsp-RGD(15) densities. [46, 47] . An overall lower BLI signal from the control CPCs injected with either HyA or HyA-PH indicated fewer cells survived in these matrices, while a more dramatic drop in BLI signal from CPCs injected with saline never recovered, consistent with previous reports indicating rapid death and clearance of cells that were transplanted in the absence of a supporting matrix [9, 48] (Fig. 6b) .
After 32 days, mice were sacrificed and the transplanted regions were inspected. In the limbs injected with hydrogels (HyA, HyA-PH, and HyA-PHT), the implant could be readily identified in the subcutaneous tissue (Fig. 6c) . Immunohistochemistry analysis of the all the hydrogel groups exhibited a high cellular density, and many of the entrained cells were GFP þ (Fig. 6d) , indicating that they were derived from the GFP þ CPCs. GFP þ CPCs were not observed at the site of saline injection ( Supplementary Fig. S7 ). Extracellular matrix production was evaluated within and around the hydrogel implants using Masson's trichrome stain and immunohistochemical staining for Type IV collagen (Fig. 7a, Supplementary Fig. S9 ). The Masson's trichome demonstrated a mesh-like network of secreted collagen matrix throughout the HyA-PHT explants, while substantially less collagen staining was observed in the HyA or HyA-PH hydrogels. Furthermore, the ECM formed within the HyA-PHT hydrogels was rich with Type IV collagen, which is typically associated with basal lamina, and the Type IV collagen was arranged into tubule structures, suggesting the implanted cells had coordinated extracellular matrix remodeling in the hydrogel to form nascent vascular structures. It is noteworthy that the other hydrogels tested, HyA and HyA-PH, were comparable in size to the HyA-PHT gels when initially explanted at day 32. However, some hydrogel was shed from the HyA and HyA-PH specimens during cryosectioning due to the low amount of matrix formation supported by these materials and therefore do not appear in the immunohistochemistry. Endothelial cell differentiation was also verified in the hydrogel implants, as the majority of the cells were positive for CD31 þ (Fig. 6d, Supplementary Fig. S8 ). Vessel stabilization was attributed to pericytes [49, 50] , and their presence within the hydrogel implants was detected by immunostaining for the pericyte marker neuron-glial antigen 2 (NG2 ; Fig 6d, Supplementary Fig. S8 ). Only HyA-PHT implants demonstrated infiltration of pericyte cells from the host tissue to implants, as the NG2 þ cells intermingled with GFP þ donor cells [49, 50] . Endomucin staining confirmed the presence of a robust vasculature, further demonstrating the enhanced vascularization within the HyA-PHT hydrogel implants. By comparison, the HyA and HyA-PH explants demonstrated minimal vascularization on the basis of endomucin staining. Finally, the explants were stained with the Alexa Fluor 568-conjugated GS-IB4 lectin via systemic perfusion through the host vasculature. Vascular structures were clearly visible in HyA-PHT explants with cross sectional areas ranging from 100 to 30,000 mm 2 ( Fig. 7a and b , Supplementary Fig. S9 ). Negligible vasculature could be discerned in the other HyA treatments after perfusion of AF-568 GS-IB4 lectin or endomucin staining. Thus, cells in the HyA-PHT hydrogels encouraged significant enhancement of vascular development in the implant, and most significantly the vasculature anastomosed with the host's circulatory system ( Fig. 7a and b , Supplementary  Fig. S9 ). Collectively, these observations indicated that MACT with the HyA-PHT implant relative to HyA and HyA-PH promoted a superior level of neovascularization with vessels that spontaneously anastomosed with the host vasculature, which were also superior relative to previously used biomaterials [28,30,51e53 ].
Discussion
In this study, a tunable approach to HyA hydrogel synthesis enabled a comprehensive investigation into gel properties that efficiently supported donor cell survival during transplantation and encouraged integration into the host tissue. We employed a modular method of HyA hydrogel synthesis that enabled independent control over both mechanical properties and biological features including: the density of peptide sequences for cell attachment via binding of integrin receptors; and, sequestration of exogenously added or endogenously synthesized growth factors via conjugated heparin. While similar systematic approaches and synthetic hydrogel matrices have been proposed for clinical use [22, 24, 54] , they have been synthesized using methods in which crosslinking molecules are necessarily put in competition with other biological agents for binding sites on the biopolymers. As a result, their mechanical properties were inversely dependent on the density of conjugated molecules used to functionalize the Fig. 7 . Extracellular matrix production and vascular tone assessed by histology a, The HyA-PHT explants exhibited strong collagen staining by Masson's trichrome, which was rich with Type IV collagen, as visualized by immunohistochemistry. Vascular tone in the explants was evaluated by endomucin staining, and integration of the hydrogels with the host vasculature was assessed by systemic perfusion of the host with Alexa Fluor 568-conjugated GS-IB4 lectin (isolectin). b, Complex vascular structures were observed in the HyA-PHT explants by reconstruction of confocal images of endomucin staining and isolectin perfusion, the latter clearly indicating the vessels within the HyA-PHT hydrogel were anastomosed with the host vessels. Scale bars ¼ 100 mm.
material. By contrast, the mechanical properties, mass swelling ratio (Q m ) and sol fraction of the hydrogel system developed in this work were dependent on both total weight percentage of HyA and the concentration of peptide crosslinkers ( Supplementary Fig. S4 ), but independent of the biological features that were incorporated on the other AcHyA hydrogel components. With this approach it was possible to overcome several limitations previously reported for MACT systems [22, 24, 55] such as: (1) compromised crosslinking efficiencies due to competition between macromer chains and other bioactive moieties in the hydrogel network; and, (2) unpolymerized soluble adhesion ligands entrained in the material acting as antagonists [22, 24] . Significantly, the material design space was not constrained by any dependencies between the hydrogel components (Supplementary Table S1 ), and therefore we could evaluate different HyA-hydrogels based on first-principles of cellematerial interactions without limitations imposed by the method of synthesis. Exogenous TGFb1 was used in this study based on its role in promoting capillary tube formation by CPCs [44] and endothelial cells [45] . Based on previous work [27, 56, 57] , we anticipated that presentation of TGFb1 by heparin would substantially facilitate its function by retaining it in an active form and in close proximity to the donor CPCs. Our findings confirmed the significance of the covalently conjugated heparin component of the HyA hydrogels to direct cell function [29, 58, 59] , as an equimolar concentration of TGFb1 supplied as a soluble mediator either within or external to HyA-P hydrogels lacking heparin was insufficient to generate a similar network formation response, as revealed by lower CD31 expression and Ac-LDL uptake ( Fig. 4; Supplementary Fig. S10 & S11). By contrast, the HyA-PHT hydrogels promoted the formation of a robust network, and this observation depended not only on TGFb1's presence, but also on the solid phase presentation of TGFb1 via its heparin-binding domain through electrostatic interactions [60] . Heparin association is known to protect growth factors from proteolytic degradation, enable growth factor prolonged bioactivity, and act as a co-receptor for growth factors to exert their biological effects on stem cells [28, 29] .
We further observed that the heparin retained angiogenic factors that were expressed by the entrained CPCs that exhibited either a heparin-binding domain and/or a basic isoelectric point (e.g., IGFBP-2, 3, CXCL16, Serpin F1 & E1, Endostatin, IL10, IP10; Fig. 5 ). Significantly, we demonstrated that addition of heparin in the HyA hydrogels was necessary to coordinate the presentation of exogenously added TGFb1 and to support the trophic functions of the CPCs by sequestering multiple secreted angiogenic factors within the matrix. These sequestered growth factors were presented within the crosslinked polymer (i.e., solid phase), thereby enhancing their effectiveness in the hydrogel. The net result was retention and solid phase presentation of a wide array of angiogenic growth factors within the hydrogel, which enabled a prolonged bioactive effect on the entrained CPCs.
In vivo, we demonstrated that HyA hydrogels carrying electrostatically bound TGFb1 through covalently conjugated heparin (HyA-PHT) promoted the highest cell survival, endothelial cell differentiation, and robust ECM development when implanted into murine hindlimbs. These hydrogels encouraged vascular development in the implant, and most significantly the vasculature anastomosed with the host's circulatory system (Figs. 6 and 7, and Supplementary Fig. S8, S9) . Thus, further engineering of the heparin component of the HyA-PHT hydrogels will be key to tuning their performance to promote stem cell survival and function for specific MACT applications.
Although the overall approach in this study was focused on CPC transplantation, these HyA hydrogels were designed for easy adaptation for other cell types and therapeutic applications.
Integration of transplanted cells with a host's vasculature is nearly a universal challenge following cell transplantation, and the heparincontaining HyA hydrogels have immense promise in a variety of MACT applications. Given the wide range of biological and mechanical parameters for these HyA hydrogels, it will be possible to engineer a matrix that promotes additional specific functions of donor cells to enhance their therapeutic potential. Therefore, we anticipate these biomaterials will be an enabling technology to improve the clinical outcomes for cell translation therapies.
Conclusion
We developed a system of hyaluronic acid (HyA)-based hydrogels and determined the role of the hydrogel components to promote Sca-1 þ /CD45 À CPCs cell survival, adhesion, endothelial cell differentiation and tubule formation. The addition of heparin in the HyA hydrogels was necessary to coordinate the presentation of TGFb1 and support the trophic functions of the CPCs by sequestering multiple endogenously secreted angiogenic factors. These HyA hydrogels also promoted in vivo CPC survival after implantation into subcutaneous murine hind-limbs and encouraged their participation in the ensuing neovascular response, including blood vessels that anastomosed with the host's blood vessels. These findings illustrate that hydrogels that sequester both exogenously added and endogenously synthesized growth factors are a promising strategy for improving survival of transplanted progenitor cells. 
